Vir Biotechnology, Inc. VIR Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$437.99M+16.1% | -$521.96M+15.1% | -$615.12M— | —— | ||
| $11.68M-19.8% | $14.56M-24.2% | $19.22M+180% | $6.87M+28.3% | ||
| $49.07M-37.5% | $78.46M-29.5% | $111.32M+9.0% | $102.08M+21.8% | ||
| -$391.78M+12.2% | -$446.35M+42.7% | -$778.79M-147% | $1.66B— | ||
| $4.83M-33.8% | $7.3M-66.2% | $21.57M-68.3% | $68.01M+212% | ||
| $310.37M-37.8% | $499.37M— | —— | -$1.19B-748% | ||
| $3.79M-13.7% | $4.39M-41.3% | $7.48M-78.5% | $34.76M-65.4% | ||
| —— | —— | -$606.68M— | —— | ||
| -$396.61M+12.6% | -$453.65M+43.3% | -$800.36M-150% | $1.6B+2,398% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Vir Biotechnology, Inc.'s cash flow data come from?
- Every line is extracted from Vir Biotechnology, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.